China Medicine Statistics

Total Valuation

China Medicine has a market cap or net worth of 7,174.

Market Cap	7,174
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

China Medicine has 23.91 million shares outstanding.

Current Share Class	23.91M
Shares Outstanding	23.91M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-1.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.00
PB Ratio	0.00
P/TBV Ratio	0.00
P/FCF Ratio	0.00
P/OCF Ratio	0.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.15, with a Debt / Equity ratio of 0.03.

Current Ratio	11.15
Quick Ratio	2.97
Debt / Equity	0.03
Debt / EBITDA	0.30
Debt / FCF	0.63
Interest Coverage	51.79

Financial Efficiency

Return on equity (ROE) is 6.63% and return on invested capital (ROIC) is 8.15%.

Return on Equity (ROE)	6.63%
Return on Assets (ROA)	7.82%
Return on Invested Capital (ROIC)	8.15%
Return on Capital Employed (ROCE)	9.32%
Revenue Per Employee	234,004
Profits Per Employee	-403
Employee Count	281
Asset Turnover	0.70
Inventory Turnover	6.33

Taxes

In the past 12 months, China Medicine has paid 3.76 million in taxes.

Income Tax	3.76M
Effective Tax Rate	39.66%

Stock Price Statistics

The stock price has increased by +100.00% in the last 52 weeks. The beta is 205.63, so China Medicine's price volatility has been higher than the market average.

Beta (5Y)	205.63
52-Week Price Change	+100.00%
50-Day Moving Average	0.00
200-Day Moving Average	0.03
Relative Strength Index (RSI)	47.04
Average Volume (20 Days)	6,738

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	29.49

Income Statement

In the last 12 months, China Medicine had revenue of 65.76 million and -113,323 in losses. Loss per share was -0.01.

Revenue	65.76M
Gross Profit	22.00M
Operating Income	11.71M
Pretax Income	9.48M
Net Income	-113,323
EBITDA	13.41M
EBIT	11.71M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 7.85 million in cash and 4.05 million in debt, giving a net cash position of 3.81 million or 0.16 per share.

Cash & Cash Equivalents	7.85M
Total Debt	4.05M
Net Cash	3.81M
Net Cash Per Share	0.16
Equity (Book Value)	125.52M
Book Value Per Share	1.97
Working Capital	85.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.01 million and capital expenditures -4.58 million, giving a free cash flow of 6.43 million.

Operating Cash Flow	11.01M
Capital Expenditures	-4.58M
Free Cash Flow	6.43M
FCF Per Share	0.27

Full Cash Flow Statement

Margins

Gross margin is 33.46%, with operating and profit margins of 17.80% and 9.17%.

Gross Margin	33.46%
Operating Margin	17.80%
Pretax Margin	14.42%
Profit Margin	9.17%
EBITDA Margin	20.39%
EBIT Margin	17.80%
FCF Margin	9.78%

Dividends & Yields

China Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-107.86%
Shareholder Yield	n/a
Earnings Yield	-1,579.63%
FCF Yield	89,635.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

China Medicine has an Altman Z-Score of 5.8 and a Piotroski F-Score of 5.

Altman Z-Score	5.8
Piotroski F-Score	5